Cetuximab treatment of metastasis-derived organoids (LMO)
Cetuximab treatment in organoids
- 62 samples
- DAC: EGAC00001002867
- Technology: unspecified
Cetuximab treatment of metastasis-derived organoids (LMO)
Dataset not to be published yet
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001006601 | RNASeq |